Leronlimab's Phase III s/c Trial is unblinded & is
Post# of 148173
(Total Views: 695)
Posted On: 01/21/2021 11:04:40 PM
Leronlimab's Phase III s/c Trial is unblinded & is now locked, correct? What does locked mean? (All data from all trial sites is in & no more will be accepted?)
The next big step is completing the Top LIne Report and getting it to the FDA with an EUA application.
Last time I asked this question, I only got 1 response, but it would be quite meaningful and negative for shorts, if Dr Nader P. released to us some data?
Might he release any data to us, such as the deaths in placebo group and deaths in leronlimab group, when the Top LIne Report is completed and thus prior to a decision is made about EUA approval?? If we knew those numbers, we could estimate the p value.
Known negative information or data some say, must be released to stock holders within 4 days? This would support thinking that recent silence is good news.
The next big step is completing the Top LIne Report and getting it to the FDA with an EUA application.
Last time I asked this question, I only got 1 response, but it would be quite meaningful and negative for shorts, if Dr Nader P. released to us some data?
Might he release any data to us, such as the deaths in placebo group and deaths in leronlimab group, when the Top LIne Report is completed and thus prior to a decision is made about EUA approval?? If we knew those numbers, we could estimate the p value.
Known negative information or data some say, must be released to stock holders within 4 days? This would support thinking that recent silence is good news.
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼